1.
Haque T,
Talukder MM. Chemical enhancer: A simplistic way to modulate barrier function
of the stratum corneum. Advanced pharmaceutical bulletin. 2018 Jun;8(2):169.
2.
Katz M,
Poulsen BJ. Absorption of drugs through the skin. In Concepts in Biochemical
Pharmacology: Part 1 1971 (pp. 103-174). Berlin, Heidelberg: Springer Berlin
Heidelberg.
3.
Benson HA,
Watkinson AC, editors. Topical and transdermal drug delivery: principles and
practice. John Wiley & Sons; 2012 Feb 3.
4.
Brown MB,
Martin GP, Jones SA, Akomeah FK. Dermal and transdermal drug delivery systems:
current and future prospects. Drug delivery. 2006 Jan 1;13(3):175-87.
5.
Schäfer-Korting
M, Mehnert W, Korting HC. Lipid nanoparticles for improved topical application
of drugs for skin diseases. Advanced drug delivery reviews. 2007 Jul
10;59(6):427-43.
6.
Harding CR.
The stratum corneum: structure and function in health and disease. Dermatologic
therapy. 2004 Feb;17:6-15.
7.
Lin TK,
Zhong L, Santiago JL. Anti-inflammatory and skin barrier repair effects of
topical application of some plant oils. International journal of molecular
sciences. 2017 Dec 27;19(1):70.
8.
Elias PM.
Epidermal lipids, barrier function, and desquamation. Journal of Investigative
Dermatology. 1983 Jun 15;80.
9.
Hao Y, Li
W, Zhou X, Yang F, Qian Z. Microneedles-based transdermal drug delivery
systems: a review. Journal of biomedical nanotechnology. 2017 Dec
1;13(12):1581-97.
10. Ramadon D, McCrudden MT, Courtenay AJ, Donnelly
RF. Enhancement strategies for transdermal drug delivery systems: Current
trends and applications. Drug delivery and translational research. 2021 Jan
20:1-34.
11. Moradi L, Javanmardi S, Abolmaali S, Mohammadi
Samani S. Passive enhancement of transdermal drug delivery: lipid-based
colloidal carriers as an emerging pharmaceutical technology platform. Trends in
Pharmaceutical Sciences. 2019 Mar 1;5(1):25-40.
12. Choudhary N, Singh AP, Singh AP. Transdermal
drug delivery system: A review. IJPP. 2021;8:5-9.
13. Zaid Alkilani A, McCrudden MT, Donnelly RF.
Transdermal drug delivery: Innovative pharmaceutical developments based on
disruption of the barrier properties of the stratum corneum. Pharmaceutics.
2015 Oct 22;7(4):438-70.
14. Arora A, Prausnitz MR, Mitragotri S.
Micro-scale devices for transdermal drug delivery. International journal of
pharmaceutics. 2008 Dec 8;364(2):227-36.
15. Tuan-Mahmood TM, McCrudden MT, Torrisi BM,
McAlister E, Garland MJ, Singh TR, Donnelly RF. Microneedles for intradermal
and transdermal drug delivery. European Journal of Pharmaceutical Sciences.
2013 Dec 18;50(5):623-37.
16. Zaid Alkilani A, McCrudden MT, Donnelly RF.
Transdermal drug delivery: Innovative pharmaceutical developments based on
disruption of the barrier properties of the stratum corneum. Pharmaceutics.
2015 Oct 22;7(4):438-70.
17. Rehman K, Zulfakar MH. Recent advances in gel
technologies for topical and transdermal drug delivery. Drug development and
industrial pharmacy. 2014 Apr 1;40(4):433-40.
18. Kumar B, Pandey M, Aggarwal R, Sahoo PK. A
comprehensive review on invasomal carriers incorporating natural terpenes for
augmented transdermal delivery. Future Journal of Pharmaceutical Sciences. 2022
Dec 2;8(1):50.
19. Prasanthi D, Lakshmi PK. Vesicles-mechanism of
transdermal permeation: a review. Asian J Pharm Clin Res. 2012;5(1):18-25.
20. Dragicevic-Curic N, Friedrich M, Petersen S,
Scheglmann D, Douroumis D, Plass W, Fahr A. Assessment of fluidity of different
invasomes by electron spin resonance and differential scanning calorimetry.
International journal of pharmaceutics. 2011 Jun 30;412(1-2):85-94.
21. Chen M, Liu X, Fahr A. Skin delivery of ferulic
acid from different vesicular systems. Journal of biomedical nanotechnology.
2010 Oct 1;6(5):577-85.
22. Lasch J, Wohlrab W. Liposome-bound cortisol: a
new approach to cutaneous therapy. Biomedica Biochimica Acta. 1986 Jan
1;45(10):1295-9.
23. Touitou E, Dayan N, Bergelson L, Godin B, Eliaz
M. Ethosomes—novel vesicular carriers for enhanced delivery: characterization
and skin penetration properties. Journal of controlled release. 2000 Apr
3;65(3):403-18.
24. Cevc G, Blume G. Lipid vesicles penetrate into
intact skin owing to the transdermal osmotic gradients and hydration force.
Biochimica et Biophysica Acta (BBA)-Biomembranes. 1992 Feb 17;1104(1):226-32.
25. Buchiraju R, Nama S, Sakala B, Chandu BR, Kommu
A, Chebrolu JK, Yedulapurapu N. Research Journal of Pharmaceutical, Biological
and Chemical Sciences.
26. Purabisaha RK, Rawat SS, Prakash A. A Review On
Novel Drug Delivery System.
27. Nangare S, Dugam S. Smart invasome synthesis,
characterizations, pharmaceutical applications, and pharmacokinetic
perspective: a review. Future Journal of Pharmaceutical Sciences. 2020
Dec;6:1-21.
28. Prasanthi D, K Lakshmi P. Iontophoretic
transdermal delivery of finasteride in vesicular invasomal carriers. Pharmaceutical
Nanotechnology. 2013 Apr 1;1(2):136-50.
29. Gupta MK, Tate SS, Vitthal DG, Phadtare GR.
Formulation and Evaluation of Ketoconazole Loaded Invasomal Gel for Effective
Topical Fungal Treatment. Neuroquantology. 2022;20(17):2139.
30. Deoghoria F, Rathi JC, Sharma R. FORMULATION
AND EVALUATION OF INVASOMES OF TAZAROTENE FOR POTENT ANTI ACNE EFFECT.
31. Moser K, Kriwet K, Naik A, Kalia YN, Guy RH.
Passive skin penetration enhancement and its quantification in vitro. European
journal of pharmaceutics and Biopharmaceutics. 2001 Sep 1;52(2):103-12.
32. Dwivedi M, Sharma V, Pathak K. Pilosebaceous
targeting by isotretenoin-loaded invasomal gel for the treatment of
eosinophilic pustular folliculitis: optimization, efficacy and cellular
analysis. Drug development and industrial pharmacy. 2017 Feb 1;43(2):293-304.
33. Pathak K, Sharma V, Sharma M. Optimization, in
vitro cytotoxicity and penetration capability of deformable nanovesicles of
paclitaxel for dermal chemotherapy in Kaposi sarcoma. Artificial Cells,
Nanomedicine, and Biotechnology. 2016 Oct 2;44(7):1671-83.
34. Jain S, Tripathi S, Tripathi PK. Invasomes:
Potential vesicular systems for transdermal delivery of drug molecules. Journal
of Drug Delivery Science and Technology. 2021 Feb 1;61:102166.
35. Singh D. Ultradeformable system: A carrier for
transdermal drug delivery. International Journal of Pharmaceutical Sciences and
Research. 2013 Nov 1;4(11):4098.
36. Babaie S, Del Bakhshayesh AR, Ha JW,
Hamishehkar H, Kim KH. Invasome: A novel nanocarrier for transdermal drug
delivery. Nanomaterials. 2020 Feb 17;10(2):341.
37. Salih OS. Invasomes as a Novel Delivery Carrier
for Transdermal Delivery: Review Article. Medicon Pharmaceutical Sciences.
2022;2:11-6.
38. Qadri GR, Ahad A, Aqil M, Imam SS, Ali A.
Invasomes of isradipine for enhanced transdermal delivery against hypertension:
formulation, characterization, and in vivo pharmacodynamic study. Artificial
cells, nanomedicine, and biotechnology. 2017 Jan 2;45(1):139-45.
39. El-Nabarawi MA, Shamma RN, Farouk F, Nasralla
SM. Dapsone-loaded invasomes as a potential treatment of acne: preparation,
characterization, and in vivo skin deposition assay. Aaps Pharmscitech. 2018
Jul;19:2174-84.
40. Dragicevic-Curic N, Scheglmann D, Albrecht V,
Fahr A. Temoporfin-loaded invasomes: development, characterization and in vitro
skin penetration studies. Journal of Controlled Release. 2008 Apr
7;127(1):59-69.
41. Shah SM, Ashtikar M, Jain AS, Makhija DT, Nikam
Y, Gude RP, Steiniger F, Jagtap AA, Nagarsenker MS, Fahr A. LeciPlex,
invasomes, and liposomes: A skin penetration study. International journal of
pharmaceutics. 2015 Jul 25;490(1-2):391-403.
42. Kumar B. Development of Curcumin Loaded
Invasomal Gel for the Treatment of Psoriasis Formulation Characterization and
In Vivo Studies.
43. Kumar B, Sahoo PK, Manchanda S. Formulation,
characterization and ex vivo study of curcumin nano-invasomal gel for enhanced
transdermal delivery. OpenNano. 2022 Jul 1;7:100058.
44. Kumari S, Alsaidan OA, Mohanty D, Zafar A, Das
S, Gupta JK, Khalid M. Development of Soft Luliconazole Invasomes Gel for Effective
Transdermal Delivery: Optimization to In-Vivo Antifungal Activity. Gels. 2023
Aug 3;9(8):626.
45. Dos Anjos JL, de Sousa Neto D, Alonso A.
Effects of 1, 8-cineole on the dynamics of lipids and proteins of stratum
corneum. International journal of pharmaceutics. 2007 Dec 10;345(1-2):81-7.
46. Duangjit S, Nimcharoenwan T, Chomya N,
Locharoenrat N, Ngawhirunpat T. Design and development of optimal invasomes for
transdermal drug delivery using computer program. asian journal of
pharmaceutical sciences. 2016 Feb 1;11(1):52-3.
47. Lakshmi PK, Kalpana B, Prasanthi D.
Invasomes-novel vesicular carriers for enhanced skin permeation. Systematic
Reviews in Pharmacy. 2013 Jan 1;4(1).
48. Afreen U, Shailaja AK. Overall review on
invasomes. Research Journal of Nanoscience and Engineering. 2019;3(4):5-9.
49. Ahmed OA, Badr-Eldin SM. Development of an
optimized avanafil-loaded invasomal transdermal film: Ex vivo skin permeation
and in vivo evaluation. International journal of pharmaceutics. 2019 Oct
30;570:118657.
50. Dragicevic N, Verma DD, Fahr A. Invasomes:
Vesicles for enhanced skin delivery of drugs. In Percutaneous Penetration
Enhancers Chemical Methods in Penetration Enhancement: Nanocarriers 2016 (pp.
77-92). Berlin, Heidelberg: Springer Berlin Heidelberg.
51. Vidya K, Lakshmi PK. Cytotoxic effect of
transdermal invasomal anastrozole gel on MCF-7 breast cancer cell line. Journal
of Applied Pharmaceutical Science. 2019 Mar 29;9(3):050-8.
52. Al-Lawati H, Aliabadi HM, Makhmalzadeh BS,
Lavasanifar A. Nanomedicine for immunosuppressive therapy: achievements in
pre-clinical and clinical research. Expert opinion on drug delivery. 2018 Apr
3;15(4):397-418.